Free access
Issue
Vet. Res.
Volume 40, Number 5, September-October 2009
Number of page(s) 12
DOI http://dx.doi.org/10.1051/vetres/2009024
Published online 30 April 2009
How to cite this article Vet. Res. (2009) 40:42
References of  Vet. Res. (2009) 40:42
  1. Acin C., Martin-Burriel I., Monleon E., Rodellar C., Badiola J.J., Zaragoza P., PrP polymorphisms Spanish sheep affected with natural scrapie, Vet. Rec. (2004) 155:370–372 [PubMed].
  2. Bolea R., Monleon E., Schiller I., Raeber A. Acin C., Monzon M., et al., Comparison of immunohistochemistry and two rapid tests for detection abnormal prion protein in different brain regions sheep with typical scrapie, J. Vet. Diagn. Invest. (2005) 17:467–469 [PubMed].
  3. Brenner C., Cadiou H., Vieira H.L., Zamzami N., Marzo I., Xie Z., et al., Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator, Oncogene (2000) 19:329–336 [CrossRef] [PubMed].
  4. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., et al., Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases), Brain Pathol. (1995) 5:459–466 [CrossRef] [PubMed].
  5. Cuconati A., Mukherjee C., Perez D., White DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells, Genes Dev. (2003) 17:2922–2932 [CrossRef] [PubMed].
  6. Choe W., Stoica G., Lynn W., Wong P.K., Neurodegeneration induced by MoMuLV-ts1 and increased expression of Fas and TNF-alpha in the central nervous system, Brain Res. (1998) 779:1–8 [CrossRef] [PubMed].
  7. Chou A.H., Yeh T.H., Kuo Y.L., Kao Y.C., Jou M.J., Hsu C.Y., et al., Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway upregulating Bax and downregulating Bcl-xL, Neurobiol. Dis. (2006) 21:333–345 [CrossRef] [PubMed].
  8. Diedrich J.F., Bendheim P.E., Kim Y.S., Carp R.I., Haase A.T., Scrapie-associated prion protein accumulates in astrocytes during scrapie infection, Proc. Natl. Acad. Sci. USA (1991) 88:375–379 [CrossRef] [PubMed].
  9. Elmore S., Apoptosis: a review of programmed cell death, Toxicol. Pathol. (2007) 35:495–516 [CrossRef] [PubMed].
  10. Ettaiche M., Pichot R., Vincent J.P., Chabry J., In vivo cytotoxicity of the prion protein fragment 106–126, J. Biol. Chem. (2000) 275:36487–36490 [CrossRef] [PubMed].
  11. Ferrer I., Puig B., Krupinsk J., Carmona M., Blanco R., Fas and Fas ligand expression in Alzheimer's disease, Acta Neuropathol. (2001) 102:121–131 [PubMed].
  12. Gray F., Chretien F., Adle-Biassette H., Dorandeu A., Ereau T., Delisle M.B., et al., Neuronal apoptosis in Creutzfeldt-Jakob disease, J. Neuropathol. Exp. Neurol. (1999) 58:321–328 [CrossRef] [PubMed].
  13. Green D.R., Kroemer G., The pathophysiology of mitochondrial cell death, Science (2004) 305:626–629 [CrossRef] [PubMed].
  14. Grell M., Zimmermann G., Hulser D., Pfizenmaier K., Scheurich P., TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways, J. Immunol. (1994) 153:1963–1972 [PubMed].
  15. Hardt M., Baron T., Groschup M.H., A comparative study of immunohistochemical methods for detecting abnormal prion protein with monoclonal and polyclonal antibodies, J. Comp. Pathol. (2000) 122:43–53 [CrossRef] [PubMed].
  16. Igney F.H., Krammer P.H., Death and anti-death: tumour resistance to apoptosis, Nat. Rev. Cancer (2002) 2:277–288 [CrossRef] [PubMed].
  17. Jamieson E., Jeffrey M., Ironside J.W., Fraser J.R., Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie, Neuroreport (2001) 12:2147–2153 [CrossRef] [PubMed].
  18. Jia L., Srinivasula S.M., Liu F.T., Newland A.C., Fernandes-Alnemri T., Alnemri E.S., Kelsey S.M., Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells, Blood (2001) 98:414–421 [CrossRef] [PubMed].
  19. Kim Y.S., Carp R.I., Callahan S., Wisniewski H.M., Incubation periods and histopathological changes in mice injected stereotaxically in different brain areas with the 87V scrapie strain, Acta Neuropathol. (Berl.) (1990) 80:388–392 [CrossRef].
  20. Kitamura Y., Shimohama S., Kamoshima W., Ota T., Matsuoka Y., Nomura Y., et al., Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease, Brain Res. (1998) 780:260–269 [CrossRef] [PubMed].
  21. Kroemer G., Zamzami N., Susin S.A., Mitochondrial control of apoptosis, Immunol. Today (1997) 18:44–51 [CrossRef] [PubMed].
  22. Lazarini F., Boussin F., Deslys J.P., Tardy M., Dormont D., Astrocyte gene expression in experimental mouse scrapie, J. Comp. Pathol. (1994) 111:87–98 [CrossRef] [PubMed].
  23. Liberski P.P., Sikorska B., Bratosiewicz-Wasik J., Gajdusek D.C., Brown P., Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy, Int. J. Biochem. Cell Biol. (2004) 36:2473–2490 [CrossRef] [PubMed].
  24. Lyahyai J., Bolea R., Serrano C., Vidal E., Pumarola M., Badiola J.J., et al., Differential expression and protein distribution of Bax in natural scrapie, Brain Res. (2007) 1180:111–120 [CrossRef] [PubMed].
  25. Martinez M., Fernandez-Vivancos E., Frank A., De la Fuente M., Hernanz A., Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations, Brain Res. (2000) 869:216–219 [CrossRef] [PubMed].
  26. Puig B., Ferrer I., Cell death signaling in the cerebellum in Creutzfeldt-Jakob disease, Acta Neuropathol. (2001) 102:207–215 [PubMed].
  27. Roucou X., Giannopoulos P.N., Zhang Y., Jodoin J., Goodyer C.G., LeBlanc A., Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells, Cell Death Differ. (2005) 12:783–795 [CrossRef] [PubMed].
  28. Saas P., Boucraut J., QuiquerezA.L., SchnurigerV., Perrin G., Desplat-Jego S., et al., CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J. Immunol. (1999) 162:2326–2333.
  29. Sajan F.D., Martiniuk F., Marcus D.L., Frey W.H. 2nd, Hite R., Bordayo E.Z., Freedman M.L., Apoptotic gene expression in Alzheimer's disease hippocampal tissue, Am. J. Alzheimers Dis. Other Demen. (2007) 22:319–328 [CrossRef] [PubMed].
  30. Sakudo A., Lee D.C., Saeki K., Matsumoto Y., Itohara S., Onodera T., Tumor necrosis factor attenuates prion protein-deficient neuronal cell death by increases in anti-apoptotic Bcl-2 family proteins, Biochem. Biophys. Res. Commun. (2003) 310:725–729 [CrossRef] [PubMed].
  31. Santee S.M., Owen-Schaub L.B., Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization, J. Biol. Chem. (1996) 271:21151–21159 [CrossRef] [PubMed].
  32. Sawada M., Brain cytokine network and novel characteristics of microglia, Nihon Shinkei Seishin Yakurigaku Zasshi (1999) 19:151–154 [PubMed] (in Japanese).
  33. Shimizu S., Narita M., Tsujimoto Y., Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC, Nature (1999) 399:483–487 [CrossRef] [PubMed].
  34. Siso S., Puig B., Varea R., Vidal E., Acin C., Prinz M., et al., Abnormal synaptic protein expression and cell death in murine scrapie, Acta Neuropathol. (Berl.) (2002) 103:615–626 [CrossRef].
  35. Stobart M.J., Parchaliuk D., Simon S.L., Lemaistre J., Lazar J., Rubenstein R., Knox J.D., Differential expression of interferon responsive genes in rodent models of transmissible spongiform encephalopathy disease, Mol. Neurodegener. (2007) 2:5 [CrossRef] [PubMed].
  36. Stoka V., Turk V., Bredesen D.E., Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing, FEBS Lett. (2006) 580:3739–3745 [CrossRef] [PubMed].
  37. Theil D., Fatzer R., Meyer R., Schobesberger M., Zurbriggen A., Vandevelde M., Nuclear DNA fragmentation and immune reactivity in bovine spongiform encephalopathy, J. Comp. Pathol. (1999) 121:357–367 [CrossRef] [PubMed].
  38. Van Everbroeck B., Dewulf E., Pals P., Lubke U., Martin J.J., Cras P., The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease, Neurobiol. Aging (2002) 23:59–64 [CrossRef] [PubMed].
  39. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol. (2002) 3:RESEARCH0034.
  40. Vargas F., Lujan L., Bolea R., Monleon E., Martin-Burriel I., Fernandez A., et al., Detection and clinical evolution of scrapie in sheep by 3rd eyelid biopsy, J. Vet. Intern. Med. (2006) 20:187–193 [CrossRef] [PubMed].
  41. Wang H.L., Yeh T.H., Chou A.H., Kuo Y.L., Luo L.J., He C.Y., et al., Polyglutamine-expanded ataxin-7 activates mitochondrial apoptotic pathway of cerebellar neurons by upregulating Bax and downregulating Bcl-x(L), Cell. Signal. (2006) 18:541–552 [CrossRef] [PubMed].
  42. Williams A., Lucassen P.J., Ritchie D., Bruce M., PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie, Exp. Neurol. (1997) 144:433–438 [CrossRef] [PubMed].
  43. Wolf B.B., Schuler M., Li W., Eggers-Sedlet B., Lee W., Tailor P., et al., Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity, J. Biol. Chem. (2001) 276:34244–34251 [CrossRef] [PubMed].
  44. Wyss-Coray T., Mucke L., Inflammation in neurodegenerative disease – a double-edged sword, Neuron (2002) 35:419–432 [CrossRef] [PubMed].
  45. Yakovlev A.G., Ota K., Wang G., Movsesyan V., Bao W.L., Yoshihara K., Faden A.I., Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury, J. Neurosci. (2001) 21:7439–7446 [PubMed].
  46. Yao M., Nguyen T.V., Pike C.J., Beta-amyloidinduced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w, J. Neurosci. (2005) 25:1149–1158 [CrossRef] [PubMed].
  47. Zhou P., Qian L., Bieszczad C.K., Noelle R., Binder M., Levy N.B., Craig R.W., Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage, Blood (1998) 92:3226–3239 [PubMed].